1.34

1.47% -0.02

Connect Biopharma Holdings Ltd ADR (CNTB)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione

Precedente Chiudi:

$1.36

Aprire:

$1.3

Volume 24 ore:

58,129

Capitalizzazione di mercato:

$73.84M

Reddito:

Utile/perdita netta:

$-85.88M

Rapporto P/E:

-0.8543

EPS:

-1.5686

Flusso di cassa netto:

$-80.96M

1 W Prestazione:

-12.99%

1M Prestazione:

+0.75%

6M Prestazione:

+17.07%

1 anno Prestazione:

+29.29%

Intervallo 1D:

$1.30

$1.40

Portata 52W:

$0.5347

$2.84

Connect Biopharma Holdings Ltd ADR Stock (CNTB) Company Profile

Nome

Connect Biopharma Holdings Ltd ADR

Settore

Healthcare (1191)

Industria

Biotechnology (688)

Telefono

Indirizzo

12265 El Camino Real, Suite 350, San Diego

Dipendente

108

Cinguettio

Prossima data di guadagno

2024-04-16

Ultimi documenti SEC

CNTB's Discussions on Twitter

Connect Biopharma Holdings Ltd ADR Stock (CNTB) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2021-04-13	Iniziato	Jefferies	Buy
2021-04-13	Iniziato	Piper Sandler	Overweight
2021-04-13	Iniziato	SVB Leerink	Outperform

Connect Biopharma Holdings Ltd ADR Borsa (CNTB) Ultime notizie

Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire Inc.

Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors

GlobeNewswire Inc.

Are Medical Stocks Lagging Bausch Health (BHC) This Year?

Zacks Investment Research

Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

Benzinga

Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma

GlobeNewswire Inc.

Connect Biopharma to Announce Top-Line Data from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma on December 12, 2023

GlobeNewswire Inc.

Connect Biopharma Holdings Ltd ADR Azioni (CNTB) Dati Finanziari